Home > News > Nanogen Reports 2003 Fourth Quarter and Year-End
February 18th, 2004
Nanogen Reports 2003 Fourth Quarter and Year-End
Nanogen, Inc. (Nasdaq: NGEN), developer of molecular diagnostic products, today announced its financial results for the fourth quarter and year ended December 31, 2003. Total revenues for the quarter ended December 31, 2003 were $2.1 million compared to $1.7 million in the third quarter of 2003 and $12.1 million in the fourth quarter of 2002. Fourth quarter product revenue increased by 45% over the prior quarter on the basis of eight new instrument sales and one reagent rental.
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013
Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013
Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013